Ustekinumab
id:
ustekinumab-164-1474563
title:
Ustekinumab
text:
Ustekinumab, sold under the brand name Stelara among others, is a monoclonal antibody medication developed by Janssen Pharmaceuticals, for the treatment of Crohn's disease, ulcerative colitis, plaque psoriasis and psoriatic arthritis, targeting both IL-12 and IL-23. Ustekinumab is approved to treat Crohn's disease in the United States, Israel, Australia, and the European Union, and ulcerative colitis in the US, and in the EU to people who have not responded to more traditional treatments. It was
brand slug:
wiki
category slug:
encyclopedia
description:
Biopharmaceutical drug
original url:
https://en.wikipedia.org/wiki/Ustekinumab
date created:
2007-01-14T00:02:29Z
date modified:
2024-08-28T17:19:14Z
main entity:
{"identifier":"Q420305","url":"https://www.wikidata.org/entity/Q420305"}
image:
fields total:
13
integrity:
15